Intensive chemotherapy for acute myeloid leukemia differentially affects circulating T<sub>C</sub>1, T<sub>H</sub>1, T<sub>H</sub>17 and T<sub>REG </sub>cells
<p>Abstract</p> <p>Background</p> <p>Several observations suggest that immunological events early after chemotherapy, possibly during the period of severe treatment-induced cytopenia, are important for antileukemic immune reactivity in acute myeloid leukemia (AML). We t...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2010-07-01
|
Series: | BMC Immunology |
Online Access: | http://www.biomedcentral.com/1471-2172/11/38 |